MKI67 and breast carcinoma: By performing a multivariate analysis of 95GC and clinicopathological factors utilized in previous studies to assess breast cancer recurrence risk, such as age, tumor diameter, tumor grade, Ki-67, and PAM50, we were able to confirm that 95GC is a significant independent prognostic factor that influences the recurrence risk.